Vicore Pharma Holding Balance Sheet Health
Financial Health criteria checks 6/6
Vicore Pharma Holding has a total shareholder equity of SEK377.7M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK406.9M and SEK29.2M respectively.
Key information
0%
Debt to equity ratio
SEK 0
Debt
| Interest coverage ratio | n/a |
| Cash | SEK 380.42m |
| Equity | SEK 377.74m |
| Total liabilities | SEK 29.17m |
| Total assets | SEK 406.90m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 6Y4's short term assets (SEK406.9M) exceed its short term liabilities (SEK28.5M).
Long Term Liabilities: 6Y4's short term assets (SEK406.9M) exceed its long term liabilities (SEK646.0K).
Debt to Equity History and Analysis
Debt Level: 6Y4 is debt free.
Reducing Debt: 6Y4 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 6Y4 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 6Y4 has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 22.2% each year.